Search - tctmd.com

Displaying 561 - 580 of 989

Sort: Relevancy | Date

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Conference News ESC 2017

ESC Updates Guidelines for Treating STEMI Patients

Michael O'Riordan

August 27, 2017

News Industry News

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

August 22, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

L.A. McKeown

May 31, 2017

News Daily News

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

Todd Neale

May 24, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

Advertisement

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

ESC Updates Guidelines for Treating STEMI Patients

Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart Lead

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content